RARA CRAFT DATABASE for FDA Medical Devices
510(k)K221664

FDA DEVICE FACTS

CLEARinse CTS Specimen Collection and Transport System

Aardvark Medical, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 3, 2023PRODUCT CODEQBD

Indications for use

CLEARinse CTS is intended to collect and transport clinical nasal wash aspirate specimens that may contain influenza A or influenza B virus, by health care professionals, from the collection site to a laboratory or testing site. CLEARinse CTS PrimeStore MTM is intended for the stabilization, transportation and inactivation of infectious unprocessed nasal washes suspected of containing Influenza a virus RNA. PrimeStore MTM is also intended for the stabilization, specimens are suitable for use with legally marketed lateral flow immunoassays and molecular assays. CLEARinse CTS is for professional in-vitro diagnostic use. transportation and inactivation of infectious unprocessed sputum samples suspected of containing Mycobacterium tuberculosis DNA from human samples. Material Polypropylene Same General Device Characteristic Differences Specimen Type Nasal Wash Aspirate suspected of containing influenza A or B viruses Nasal wash suspected of containing Influenza A virus. Sputum samples suspected of containing MTB. Transport Media Formulation 0.9% saline from nasal wash Nucleic Acid Stabilization solution Device Material Supplied Wash Head and Transport Container Molecular Transport Medium provided in cryogenic tube Sterility Sterile Not sterile Inactivation No inactivation of viruses or bacteria Inactivation of influenza A and MTB by Guanidine thiocyanate Specimen Collection Collection using the CLEARinse Pro Handle and Instructions for Use Collection using standard clinical procedures

The Aardvark Medical Company CLEARinse CTS Device is substantially equivalent to the legally marketed predicate device. The CLEARinse CTS Device has the same intended use, similar indications for use, and similar technological characteristics for transporting nasal wash specimens to the laboratory as the predicate device. Performance data demonstrates that the CLEARinse CTS Device is as safe and effective.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026